APTEVO THERAPEUTICS INC
APVO·03835L702·US·Common Stock·Healthcare - Biotechnology-13D/G
APVO (APTEVO THERAPEUTICS INC) is held by 6 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($56,948), VANGUARD CAPITAL MANAGEMENT LLC ($54,285), VANGUARD FIDUCIARY TRUST CO ($17,686). Net institutional sentiment: Mixed.
6
Holders
Avg rating(2 Elite)
$145,168
Total Value
57% (9)
Fund Consensus
4 buying - 3 selling
Who's Trading
ActivistNINIOWAVE, INC.12.2%Jun 22, 2026
ActivistCICVI Investments, Inc.8.2%Feb 17, 2026
InsiderGIGrant Grady IIIBuy $20KNov 10, 2025
ActivistCICVI Investments, Inc.9.9%Aug 14, 2025
ActivistLGL1 Capital Global Opportunities Master Fund, Ltd.5.0%Aug 14, 2025
ActivistAYAyrton Capital LLC10.0%Aug 13, 2025
ActivistYIYA II PN, Ltd.10.0%Jul 8, 2025
ActivistBLBIGGER CAPITAL FUND L P9.9%Jun 25, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer